MDWerks, Inc. (MDWK): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

MDWerks, Inc. (MDWK) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 MDWERKS, INC. Independent Director Agreement Jeff Hopmayer Dated as of June 26, 2026 This Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered

Event · Exec change
Person
Jeff Hopmayer
Title
Board of Directors
Action
appointed

Facts are quoted from the filing text and checked against it.

Original reporting
Published Jul 10, 2026, 8:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 10, 2026, 8:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MDWK
Neutral
medium confidence
Mentioned
$MDWK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MDWKNeutralLow
01

Why it matters

This is primarily governance and committee-structure information. Without disclosed compensation figures, equity awards, or operational updates in the provided excerpt, the direct trading impact is likely small.

02

Market read

The filing updates board composition and committee leadership, which may matter for longer-term strategy but does not provide new financial or deal catalysts in the excerpt.

03

What to watch

Traders may want to check whether the agreement includes specific compensation amounts or equity grants in sections not shown here, which could affect near-term expectations.

Relevance 6/10Novelty 3/10Timing: filed after-hours on 2026-07-10, for immediate governance/positioning review

Background

The document is an SEC Form 8-K (Item 5.02) with an exhibit containing an independent director agreement for Jeff Hopmayer, dated June 26, 2026.

Company-level read

Ticker impact

$MDWKNeutralMedium confidence
Context

MDWerks filed an 8-K for Item 5.02, appointing Jeff Hopmayer as an independent director and Head of the Technology Commercialization Committee.

Expected impact

Likely limited near-term impact; any move would be sentiment-driven rather than fundamentals.

Evidence & confidence

The filing describes governance and committee service terms (independent director agreement, term length, and definitions like Cause/Good Reason) without new operating metrics, contracts, or capital actions.

Market effects

Minimal, as this is company-specific governance documentation rather than sector-wide regulatory or operational change.

None indicated.

None indicated.

Counterpoint

The appointment could signal a strategic push on technology commercialization, but the filing text provided does not include measurable milestones or funding changes.

Key entities

  • MDWerks, Inc.

    Company filing the 8-K and entering into an independent director agreement.

  • Jeff Hopmayer

    Appointed independent director and Head of the Technology Commercialization Committee under the agreement.

Related articles

$SPGIMed

S&P Global prices $2 billion senior notes offering

S&P Global (SPGI) priced a $2 billion senior notes offering in three tranches, with yields ranging from 5.635% to 6.001%. The notes are due 2031, 2034, and 2036, and proceeds will be used for general corporate purposes. The offering is expected to close around November 18, 2026, and is managed by several major financial institutions. The notes will be unsecured obligations of the company, guaranteed by a subsidiary.

$SPGIMed

S&P Global Announces Pricing of Public Offering of $750,000,000 Senior Notes due 2031, $600,000,000 Senior Notes due 2034 and $650,000,000 Senior Notes due 2036

S&P Global (NYSE: SPGI) priced a public offering of $750M, $600M, and $650M in senior notes due 2031, 2034, and 2036, respectively. The notes were priced at yields of 5.635%, 5.814%, and 6.001%. Proceeds will be used for general corporate purposes, including possible acquisitions or debt repayment. The offering is expected to close on November 18, 2026, subject to conditions.